Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Valerio Therapeutics and Abivax target next-generation therapies for inflammatory disease Valerio may gain cash and platform validation from Abivax, but definitive terms and preclinical delivery will decide whether the alliance creates value. bySrinathJuly 16, 2026